MedTrace Logo

Conservative Pulp Therapy of Primary Molars Using TheraCAL

NCT04167943 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2022-06-14

No results posted yet for this study

Summary

The study is a clinical trial that assesses the clinical and radiographic success rates of 3 conservative pulp therapy treatments in primary molars compared to conventional pulpotomy using a bioactive dual cured calcium silicate cement (TheraCAL PT).

Conditions

  • Reversible Pulpitis

Interventions

DRUG

Dual cured resin modified tricalcium silicate cement

A resin based, dual cured tricalcium silicate based cement

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mariem Wassel · Faculty of Dentistry, Ain Sham University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-25
Primary Completion
2021-08-01
Completion
2021-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167943 on ClinicalTrials.gov